ArticleFrontiers in oncology2022

Efficacy and Safety of Conversion Therapy by Intraperitoneal and Intravenous Paclitaxel Plus Oral S-1 in Gastric Cancer Patients With Peritoneal Metastasis: A Prospective Phase II Study.

Zhong-Yin Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.